Our 2025 strategy We're focused on delivering durable growth and creating shareholder value, while making appropriate investments for the future. BD 2025, our current phase of value creation, is anchored in three key pillars—Grow, Simplify and Empower. Read more at bd.com Key announcements • In April 2021 , we announced the investment of $65 million to construct a state - of-the-art facility in Tucson, Arizona, that will be a hub for the company's supply chain, serving as a final-stage manufacturing and sterilization center. • In May 2021 , we announced our intention to spin off the Diabetes Care business, to create embecta. The spin-off was completed in April 2022, and embecta is one of the largest pure-play diabetes management companies in the world. For more information, visit embecta.com . • In June 2021 , we announced that we had become the first medical technology company authorized as a Common Vulnerability and Exposures (CVE ® ) Numbering Authority by the CVE Program, further demonstrating our leadership in healthcare cybersecurity. Read more about our cybersecurity program here . • In September 2021 , we officially signed on to the Race to Zero via the Science Based Targets initiative (SBTi) and in partnership with the Business Ambition for 1.5⁰C . This milestone was celebrated at Global Citizen LIVE . • In November 2021 , we broke ground on a €165 million ($200 million) manufacturing facility in the city of Zaragoza, located in the Aragon region of Spain. The facility, which is expected to be completed in 2023, will be a sustainable and fully automated facility incorporating the latest in intelligent and autonomous solutions. The new site is part of the $1.2 billion, four - year investment that was announced in late 2020 to expand and upgrade BD’s manufacturing capacity and technology for pre - fillable syringes and advanced drug delivery systems as part of the company’s 2025 growth strategy. Key awards • Named t o Newsweek ‘s inaugural list of America’s Most Trusted Companies in the Health Care and Life Sciences category • BD R anked first in its industry in Forbes America’s Best Large Employers List • Named one of America’s Most Just Companies in the Annual JUST 100 Ranking • Named one of America’s Most Responsible Companies by Newsweek • Named t o Forbes 2022 List of Best Employers for Diversity 8 2021 ESG Report Appendices Transparency Healthy workforce and communities Responsible supply chain Product impact Climate change Introduction